Location: New York, NY
CIK: 0001773195 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 13, 2024
Total Value: $548M (95.0% shares, 5.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | IMMUNOGEN INC | 1,404,608 | $41.65M | 7.6% | $29.65 | — | COM | 45253H101 |
| — | CEREVEL THERAPEUTICS HLDNG I | 750,000 | $31.8M | 5.8% | $29.22 | — | COM | 15678U128 |
| — | CYMABAY THERAPEUTICS INC | 1,090,441 | $25.76M | 4.7% | $4.13 | — | COM | 23257D103 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 100,000 | $23.14M | 4.2% | $134.84 | +29.8% | COM | 558868105 |
| XENE | XENON PHARMACEUTICALS INC | 460,000 | $21.19M | 3.9% | $36.59 | -3.4% | COM | 98420N105 |
| — | BRIDGEBIO PHARMA INC | 17,000,000 | $20.58M | 3.8% | $0.81 | — | NOTE 2.500% 3/1 | 10806XAB8 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1,900,000 | $19.84M | 3.6% | $8.06 | — | SPONSORED ADS | 881624209 |
| ACLX | ARCELLX INC | 340,000 | $18.87M | 3.4% | $26.17 | +72.4% | COMMON STOCK | 03940C100 |
| LIANY | LIANBIO | 3,779,694 | $16.9M | 3.1% | $4.20 | — | SPONSORED ADS | 53000N108 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 447,095 | $15.91M | 2.9% | $20.61 | +48.8% | COM | 22663K107 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 400,000 | $15.86M | 2.9% | $30.58 | -3.8% | COM NEW | 15117B202 |
| APGE | APOGEE THERAPEUTICS INC | 537,093 | $15.01M | 2.7% | $22.03 | -9.0% | COM | 03770N101 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1,400,000 | $14.62M | 2.7% | $8.06 | — | Call | 881624209 |
| IMVT | IMMUNOVANT INC | 345,000 | $14.53M | 2.7% | $21.47 | +71.4% | COM | 45258J102 |
| CYTK | CYTOKINETICS INC | 160,000 | $13.36M | 2.4% | $38.37 | -5.6% | COM NEW | 23282W605 |
| NUVL | NUVALENT INC | 175,000 | $12.88M | 2.4% | $56.88 | +8.8% | COM | 670703107 |
| — | ASTRIA THERAPEUTICS INC | 1,466,465 | $11.26M | 2.1% | $8.63 | — | COM | 04635X102 |
| — | VERONA PHARMA PLC | 563,824 | $11.21M | 2.0% | $15.57 | — | SPONSORED ADS | 925050106 |
| SYRE | SPYRE THERAPEUTICS INC | 517,554 | $11.14M | 2.0% | $13.51 | +1.9% | COM NEW | 00773J202 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 1,550,408 | $9.985M | 1.8% | $2.37 | — | SPON ADS | 05280R100 |
| ALKS | ALKERMES PLC | 356,384 | $9.886M | 1.8% | $26.91 | -3.5% | SHS | G01767105 |
| — | INOZYME PHARMA INC | 1,885,802 | $8.034M | 1.5% | $3.59 | — | COM | 45790W108 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 320,100 | $7.398M | 1.4% | $11.18 | 0.0% | Put | 30233G209 |
| NRIX | NURIX THERAPEUTICS INC | 690,112 | $7.122M | 1.3% | $7.99 | -14.2% | COM | 67080M103 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 795,729 | $6.334M | 1.2% | $4.53 | — | SPONSORED ADS | 152309100 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 228,277 | $5.91M | 1.1% | $65.47 | -55.3% | COM | G31249108 |
| — | MIRATI THERAPEUTICS INC | 100,049 | $5.878M | 1.1% | $49.58 | — | COM | 60468T105 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 225,000 | $5.825M | 1.1% | $65.47 | -55.3% | Call | G31249108 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 30,000 | $5.742M | 1.0% | — | — | Call | 02043Q107 |
| ROIV | ROIVANT SCIENCES LTD | 500,000 | $5.615M | 1.0% | $10.21 | -4.6% | SHS | G76279101 |
| VKTX | VIKING THERAPEUTICS INC | 300,000 | $5.583M | 1.0% | $6.55 | +99.6% | COM | 92686J106 |
| SVRA | SAVARA INC | 1,150,000 | $5.405M | 1.0% | $3.56 | +7.5% | COM | 805111101 |
| CMPS | COMPASS PATHWAYS PLC | 550,000 | $4.813M | 0.9% | $8.75 | — | SPONSORED ADS | 20451W101 |
| APLS | APELLIS PHARMACEUTICALS INC | 75,000 | $4.489M | 0.8% | $48.94 | +3.7% | COM | 03753U106 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 70,988 | $4.287M | 0.8% | $54.12 | -4.8% | CLASS A ORD | 61559X104 |
| — | DYNAVAX TECHNOLOGIES CORP | 300,000 | $4.194M | 0.8% | $14.51 | — | COM NEW | 268158201 |
| GPCR | STRUCTURE THERAPEUTICS INC | 100,000 | $4.076M | 0.7% | — | — | Call | 86366E106 |
| AZN | ASTRAZENECA PLC | 60,000 | $4.041M | 0.7% | $61.36 | — | SPONSORED ADR | 046353108 |
| AXSM | AXSOME THERAPEUTICS INC | 50,000 | $3.979M | 0.7% | $66.86 | 0.0% | COM | 05464T104 |
| — | SPRINGWORKS THERAPEUTICS INC | 100,000 | $3.65M | 0.7% | $32.23 | — | COM | 85205L107 |
| — | OMEROS CORP | 6,000,000 | $3.6M | 0.7% | $0.60 | — | NOTE 5.250% 2/1 | 682143AG7 |
| — | COHERUS BIOSCIENCES INC | 6,000,000 | $3.403M | 0.6% | $0.57 | — | NOTE 1.500% 4/1 | 19249HAB9 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 94,300 | $3.355M | 0.6% | $20.61 | +48.8% | Put | 22663K107 |
| RLAY | RELAY THERAPEUTICS INC | 300,000 | $3.303M | 0.6% | $8.44 | 0.0% | COM | 75943R102 |
| BBIO | BRIDGEBIO PHARMA INC | 80,000 | $3.23M | 0.6% | $23.14 | +29.8% | COM | 10806X102 |
| KRYS | KRYSTAL BIOTECH INC | 25,000 | $3.102M | 0.6% | $122.00 | -9.1% | COM | 501147102 |
| CGEM | CULLINAN ONCOLOGY INC | 300,000 | $3.057M | 0.6% | $8.86 | 0.0% | COM | 230031106 |
| TNGX | TANGO THERAPEUTICS INC | 300,274 | $2.973M | 0.5% | $6.10 | +42.4% | COM | 87583X109 |
| ARGX | ARGENX SE | 7,500 | $2.853M | 0.5% | $380.43 | — | SPONSORED ADR | 04016X101 |
| KURA | KURA ONCOLOGY INC | 191,535 | $2.754M | 0.5% | $15.32 | -35.8% | COM | 50127T109 |
| SAVA | CASSAVA SCIENCES INC | 121,000 | $2.724M | 0.5% | — | — | Call | 14817C107 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 109,900 | $2.54M | 0.5% | $11.18 | 0.0% | COM NEW | 30233G209 |
| ASND | ASCENDIS PHARMA A/S | 20,000 | $2.519M | 0.5% | $108.03 | — | SPONSORED ADR | 04351P101 |
| — | MERSANA THERAPEUTICS INC | 1,000,000 | $2.32M | 0.4% | $1.27 | — | COM | 59045L106 |
| IMTX | IMMATICS N.V | 200,000 | $2.106M | 0.4% | $9.33 | -1.4% | SHS | N44445109 |
| PEN | PENUMBRA INC | 7,500 | $1.887M | 0.3% | $221.05 | 0.0% | COM | 70975L107 |
| — | TOURMALINE BIO INC | 68,081 | $1.782M | 0.3% | $26.18 | — | COM | 89157D105 |
| ADCT | ADC THERAPEUTICS SA | 1,013,540 | $1.682M | 0.3% | $2.62 | -64.7% | SHS | H0036K147 |
| PCVX | VAXCYTE INC | 25,000 | $1.57M | 0.3% | $43.78 | +18.6% | COM | 92243G108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 125,969 | $1.543M | 0.3% | $9.79 | -7.0% | COM | 483497103 |
| APLS | APELLIS PHARMACEUTICALS INC | 25,000 | $1.496M | 0.3% | $48.94 | +3.7% | Call | 03753U106 |
| MIRM | MIRUM PHARMACEUTICALS INC | 50,000 | $1.476M | 0.3% | $25.02 | +21.0% | COM | 604749101 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 125,000 | $1.396M | 0.3% | $12.78 | -28.3% | ORDINARY SHARES | N62509109 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 10,000 | $1.318M | 0.2% | $115.11 | 0.0% | COM | 64125C109 |
| — | INARI MED INC | 20,000 | $1.298M | 0.2% | $64.92 | — | COM | 45332Y109 |
| ALLO | ALLOGENE THERAPEUTICS INC | 400,000 | $1.284M | 0.2% | $2.84 | 0.0% | COM | 019770106 |
| — | MORPHIC HLDG INC | 42,670 | $1.232M | 0.2% | $39.44 | — | COM | 61775R105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 50,000 | $1.089M | 0.2% | $15.79 | 0.0% | COM | 92790C104 |
| BHVN | BIOHAVEN LTD | 20,866 | $893K | 0.2% | $20.78 | +49.6% | COM | G1110E107 |
| PBYI | PUMA BIOTECHNOLOGY INC | 202,349 | $876K | 0.2% | $3.69 | -10.2% | COM | 74587V107 |
| FULC | FULCRUM THERAPEUTICS INC | 125,000 | $844K | 0.2% | $4.44 | 0.0% | COM | 359616109 |
| ALKS | ALKERMES PLC | 27,000 | $749K | 0.1% | $26.91 | -3.5% | Put | G01767105 |
| — | AVROBIO INC | 500,000 | $680K | 0.1% | $1.54 | — | COM | 05455M100 |
| — | IMMATICS N.V | 187,204 | $547K | 0.1% | $2.88 | — | W EXP 07/01/202 | N44445117 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 137,000 | $429K | 0.1% | $1.89 | — | W EXP 11/22/202 | N62509117 |
| TERN | TERNS PHARMACEUTICALS INC | 66,000 | $428K | 0.1% | $6.35 | -16.7% | COM | 880881107 |
| NUVB | NUVATION BIO INC | 250,000 | $378K | 0.1% | $2.02 | -36.4% | COM CL A | 67080N101 |
| CNTX | CONTEXT THERAPEUTICS INC | 328,817 | $372K | 0.1% | $0.90 | +18.9% | COM | 21077P108 |
| IFRX | INFLARX NV | 200,097 | $326K | 0.1% | $4.30 | -60.2% | COM | N44821101 |
| — | PROMIS NEUROSCIENCES INC | 265,958 | $306K | 0.1% | $1.98 | — | COM NEW | 74346M406 |
| — | ARAVIVE INC | 346,511 | $42,863 | 0.0% | $0.13 | — | COM | 03890D108 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 75,000 | $36,750 | 0.0% | $0.16 | — | W EXP 09/02/202 | 77313F114 |